This company seems to have been delisted
Reason: Acquired by Kyowa Kirin
Last recorded trade on: March 20, 2024
Source: https://www.ns-healthcare.com/news/kyowa-kirin-wraps-up-acquisition-of-orchard-therapeutics/
Reason: Acquired by Kyowa Kirin
Last recorded trade on: March 20, 2024
Source: https://www.ns-healthcare.com/news/kyowa-kirin-wraps-up-acquisition-of-orchard-therapeutics/
Orchard Therapeutics
ORTX
$22.25
Share price
0.00%
Change (1 day)
240.43%
Change (1 year)
Orchard Therapeutics (ORTX) - P/B ratio
P/B ratio as of April 2025 : 4.74
According to Orchard Therapeutics
's latest financial reports the company has a price-to-book ratio of 17.405.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Orchard Therapeutics - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.66 | 873.87% |
| 2022-12-31 | 0.4783 | -39.38% |
| 2021-12-31 | 0.7890 | -66.84% |
| 2020-12-31 | 2.38 | -46.58% |
| 2019-12-31 | 4.45 | 2.68% |
| 2018-12-31 | 4.34 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 5.18 | 9.41% | Jersey |
 | -1.44 | -130.49% | 🇺🇸 USA |
 | 10.7 | 126.58% | 🇺🇸 USA |
 | 4.74 | 0.00% | 🇬🇧 UK |